Red Cedar Capital’s Avanos Medical AVNS Stock Holding History

Red Cedar Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3K	Hold	92	–	–	﹤0.01%	159
2022 Q3	$2K	Hold	92	–	–	﹤0.01%	167
2022 Q2	$3K	Hold	92	–	–	﹤0.01%	146
2022 Q1	$3K	Hold	92	–	–	﹤0.01%	145
2021 Q4	$3K	Hold	92	–	–	﹤0.01%	138
2021 Q3	$3K	Hold	92	–	–	﹤0.01%	130
2021 Q2	$3K	Hold	92	–	–	﹤0.01%	131
2021 Q1	$4K	Hold	92	–	–	﹤0.01%	129
2020 Q4	$4K	Hold	92	–	–	﹤0.01%	123
2020 Q3	$3K	Sell	92 -116	-56%	-$3.71K	﹤0.01%	126
2020 Q2	$6K	Hold	208	–	–	0.01%	114
2020 Q1	$6K	Hold	208	–	–	0.01%	111
2019 Q4	$7K	Hold	208	–	–	0.01%	116
2019 Q3	$8K	Hold	208	–	–	0.01%	117
2019 Q2	$9K	Hold	208	–	–	0.01%	118
2019 Q1	$8K	Hold	208	–	–	0.01%	119
2018 Q4	$9K	Buy	+208	New	+$10.9K	0.01%	118
2018 Q2	–	Sell	-208	Closed	-$10K	–	146
2018 Q1	$10K	Hold	208	–	–	0.01%	120
2017 Q4	$10K	Buy	+208	New	+$9.56K	0.01%	121

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Red Cedar Capital's AVNS Position: Q4 2022 in Review

Red Cedar Capital held its Avanos Medical (AVNS) position steady in Q4 2022 at 92 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #159.

Red Cedar Capital first reported a position in AVNS in Q4 2017 and has held it in 19 quarters since. The position peaked at $10K in Q1 2018. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

Red Cedar Capital held 92 shares of Avanos Medical worth $3K as of Q4 2022.
Red Cedar Capital left its Avanos Medical share count unchanged in Q4 2022.
Avanos Medical made up ﹤0.01% of Red Cedar Capital's portfolio in Q4 2022, its #159 holding.
Red Cedar Capital first reported a position in Avanos Medical in Q4 2017 and has held it in 19 quarters since.
Red Cedar Capital's Avanos Medical position peaked at $10K in Q1 2018.
288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.